Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Operating Lease, Payments

2.8 / 5 stars · 68/120 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Operating Lease, Payments

AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Operating Lease, Payments of $122.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:OperatingLeasePayments · last filed 2026-08-13

  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for the quarter ending 2026-06-30 was $122.00K, a 37.08% increase year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for the quarter ending 2026-03-31 was $126.00K, a 80.76% decline year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for the quarter ending 2025-12-31 was -$140.00K, a 156.45% decline year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for the quarter ending 2025-09-30 was $123.00K, a 7.52% decline year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for fiscal 2025 was $781.00K, a 67.24% increase from fiscal 2024.
  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for fiscal 2024 was $467.00K, a 54.64% increase from fiscal 2023.
  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for fiscal 2023 was $302.00K, a 25.62% decline from fiscal 2022.
  • AMERICAN SHARED HOSPITAL SERVICES operating lease, payments for fiscal 2022 was $406.00K, a 15.67% increase from fiscal 2021.
Period endOperating Lease, Payments 3 monthOperating Lease, Payments 3 month as first filedOperating Lease, Payments 6 monthOperating Lease, Payments 6 month as first filedOperating Lease, Payments 9 monthOperating Lease, Payments 12 monthOperating Lease, Payments 12 month as first filed
2026-06-30$122.00K
10-Q · filed 2026-08-13
$248.00K
10-Q · filed 2026-08-13
$108.00K
derived: sum of 3 quarters · filed 2026-08-13
$231.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$126.00K
10-Q · filed 2026-05-14
-$14.00K
derived: sum of 2 quarters · filed 2026-05-14
$109.00K
derived: sum of 3 quarters · filed 2026-05-14
$198.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$140.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31
-$17.00K
derived: sum of 2 quarters · filed 2026-03-31
$72.00K
derived: sum of 3 quarters · filed 2026-08-13
$781.00K
10-K · filed 2026-03-31
2025-09-30$123.00K
10-Q/A · filed 2026-01-16
$212.00K
derived: sum of 2 quarters · filed 2026-08-13
$921.00K
10-Q/A · filed 2026-01-16
$1.11M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$89.00K
10-Q · filed 2026-08-13
$744.00K
10-Q · filed 2026-08-13
$992.00K
derived: sum of 3 quarters · filed 2026-08-13
$1.13M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$655.00K
10-Q · filed 2026-05-14
$903.00K
derived: sum of 2 quarters · filed 2026-05-14
$1.04M
derived: sum of 3 quarters · filed 2026-05-14
$1.05M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$248.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31
$381.00K
derived: sum of 2 quarters · filed 2026-03-31
$395.00K
derived: sum of 3 quarters · filed 2026-03-31
$467.00K
10-K · filed 2026-03-31
$303.00K
10-K · filed 2025-04-04
2024-09-30$133.00K
10-Q/A · filed 2026-01-16
$147.00K
derived: sum of 2 quarters · filed 2026-01-16
$219.00K
10-Q/A · filed 2026-01-16
$205.00K
derived: sum of 4 quarters · filed 2026-01-16
2024-06-30$14.00K
10-Q · filed 2025-08-13
$35.00K
10-Q · filed 2025-08-13
$72.00K
derived: sum of 3 quarters · filed 2025-08-13
$131.00K
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$21.00K
10-Q · filed 2025-05-15
$58.00K
derived: sum of 2 quarters · filed 2025-05-15
$117.00K
derived: sum of 3 quarters · filed 2025-05-15
$220.00K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04
$96.00K
derived: sum of 2 quarters · filed 2025-04-04
$199.00K
derived: sum of 3 quarters · filed 2025-04-04
$302.00K
10-K · filed 2025-04-04
2023-09-30$59.00K
10-Q · filed 2024-11-14
$162.00K
derived: sum of 2 quarters · filed 2024-11-14
$265.00K
10-Q · filed 2024-11-14
$368.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$103.00K
10-Q · filed 2024-08-14
$206.00K
10-Q · filed 2024-08-14
$309.00K
derived: sum of 3 quarters · filed 2024-08-14
$411.00K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$103.00K
10-Q · filed 2024-05-15
$206.00K
derived: sum of 2 quarters · filed 2024-05-15
$308.00K
derived: sum of 3 quarters · filed 2024-05-15
$409.00K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$103.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$205.00K
derived: sum of 2 quarters · filed 2024-04-01
$306.00K
derived: sum of 3 quarters · filed 2024-04-01
$406.00K
10-K · filed 2024-04-01
2022-09-30$102.00K
10-Q · filed 2023-11-14
$203.00K
derived: sum of 2 quarters · filed 2023-11-14
$303.00K
10-Q · filed 2023-11-14
$396.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$101.00K
10-Q · filed 2023-08-14
$58.00K
10-Q · filed 2022-08-15
$202.00K
10-Q · filed 2023-08-14
$116.00K
10-Q · filed 2022-08-15
$294.00K
derived: sum of 3 quarters · filed 2023-08-14
$381.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$100.00K
10-Q · filed 2023-05-12
$193.00K
derived: sum of 2 quarters · filed 2023-05-12
$280.00K
derived: sum of 3 quarters · filed 2023-05-12
$366.00K
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$93.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$180.00K
derived: sum of 2 quarters · filed 2023-03-31
$266.00K
derived: sum of 3 quarters · filed 2023-03-31
$351.00K
10-K · filed 2023-03-31
2021-09-30$87.00K
10-Q · filed 2022-11-10
$173.00K
derived: sum of 2 quarters · filed 2022-11-10
$258.00K
10-Q · filed 2022-11-10
2021-06-30$86.00K
10-Q · filed 2022-08-15
$171.00K
10-Q · filed 2022-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45